We find that CIN, assessed by the two independently derived CIN expression signatures, is significantly associated with increased tumour size, ER negative or HER2 positive disease, higher tumour grade and younger age at diagnosis in ER negative breast cancer. This evidence concerns the gene ERBB2 and cervical squamous intraepithelial neoplasia.